Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:hla-dp antigen'
(id=7260075 ; fe=en:hla-dp antigen ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1494 creation date=2017-06-26 touchdate=2025-12-02 05:05:19.000)
≈ 43 relations sortantes

  1. en:hla-dp antigen -- r_associated #0: 41 / 1 -> en:hla-dp antigens
    n1=en:hla-dp antigen | n2=en:hla-dp antigens | rel=r_associated | relid=0 | w=41
  2. en:hla-dp antigen -- r_associated #0: 30 / 0.732 -> en:hla-dw12 antigens
    n1=en:hla-dp antigen | n2=en:hla-dw12 antigens | rel=r_associated | relid=0 | w=30
  3. en:hla-dp antigen -- r_associated #0: 30 / 0.732 -> en:hla-dw14 antigen
    n1=en:hla-dp antigen | n2=en:hla-dw14 antigen | rel=r_associated | relid=0 | w=30
  4. en:hla-dp antigen -- r_associated #0: 29 / 0.707 -> en:human leukocyte antigen hla-dw2 antigen
    n1=en:hla-dp antigen | n2=en:human leukocyte antigen hla-dw2 antigen | rel=r_associated | relid=0 | w=29
  5. en:hla-dp antigen -- r_associated #0: 28 / 0.683 -> antigène HLA-DP
    n1=en:hla-dp antigen | n2=antigène HLA-DP | rel=r_associated | relid=0 | w=28
  6. en:hla-dp antigen -- r_associated #0: 28 / 0.683 -> en:bioformation
    n1=en:hla-dp antigen | n2=en:bioformation | rel=r_associated | relid=0 | w=28
  7. en:hla-dp antigen -- r_associated #0: 28 / 0.683 -> en:exposure as collected domain
    n1=en:hla-dp antigen | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=28
  8. en:hla-dp antigen -- r_associated #0: 28 / 0.683 -> en:hla-dpw2 antigen
    n1=en:hla-dp antigen | n2=en:hla-dpw2 antigen | rel=r_associated | relid=0 | w=28
  9. en:hla-dp antigen -- r_associated #0: 28 / 0.683 -> en:hla-dw1 antigen
    n1=en:hla-dp antigen | n2=en:hla-dw1 antigen | rel=r_associated | relid=0 | w=28
  10. en:hla-dp antigen -- r_associated #0: 28 / 0.683 -> en:hla-dw15
    n1=en:hla-dp antigen | n2=en:hla-dw15 | rel=r_associated | relid=0 | w=28
  11. en:hla-dp antigen -- r_associated #0: 27 / 0.659 -> en:hla-dp beta-chains
    n1=en:hla-dp antigen | n2=en:hla-dp beta-chains | rel=r_associated | relid=0 | w=27
  12. en:hla-dp antigen -- r_associated #0: 27 / 0.659 -> en:hla-dr4 antigen
    n1=en:hla-dp antigen | n2=en:hla-dr4 antigen | rel=r_associated | relid=0 | w=27
  13. en:hla-dp antigen -- r_associated #0: 26 / 0.634 -> en:drug effect
    n1=en:hla-dp antigen | n2=en:drug effect | rel=r_associated | relid=0 | w=26
  14. en:hla-dp antigen -- r_associated #0: 26 / 0.634 -> en:hla-dq4 antigen
    n1=en:hla-dp antigen | n2=en:hla-dq4 antigen | rel=r_associated | relid=0 | w=26
  15. en:hla-dp antigen -- r_associated #0: 26 / 0.634 -> en:physiological aspects
    n1=en:hla-dp antigen | n2=en:physiological aspects | rel=r_associated | relid=0 | w=26
  16. en:hla-dp antigen -- r_associated #0: 26 / 0.634 -> HLA-DP
    n1=en:hla-dp antigen | n2=HLA-DP | rel=r_associated | relid=0 | w=26
  17. en:hla-dp antigen -- r_associated #0: 25 / 0.61 -> antigène
    n1=en:hla-dp antigen | n2=antigène | rel=r_associated | relid=0 | w=25
  18. en:hla-dp antigen -- r_associated #0: 25 / 0.61 -> en:hla-dq1 antigen
    n1=en:hla-dp antigen | n2=en:hla-dq1 antigen | rel=r_associated | relid=0 | w=25
  19. en:hla-dp antigen -- r_associated #0: 25 / 0.61 -> en:hla-dw13 antigen
    n1=en:hla-dp antigen | n2=en:hla-dw13 antigen | rel=r_associated | relid=0 | w=25
  20. en:hla-dp antigen -- r_associated #0: 25 / 0.61 -> en:hla-dw4 antigen
    n1=en:hla-dp antigen | n2=en:hla-dw4 antigen | rel=r_associated | relid=0 | w=25
  21. en:hla-dp antigen -- r_associated #0: 25 / 0.61 -> en:mechanism of action qualifier
    n1=en:hla-dp antigen | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=25
  22. en:hla-dp antigen -- r_associated #0: 24 / 0.585 -> en:hla-dw19 antigen
    n1=en:hla-dp antigen | n2=en:hla-dw19 antigen | rel=r_associated | relid=0 | w=24
  23. en:hla-dp antigen -- r_associated #0: 24 / 0.585 -> en:hla-dw5 antigen
    n1=en:hla-dp antigen | n2=en:hla-dw5 antigen | rel=r_associated | relid=0 | w=24
  24. en:hla-dp antigen -- r_associated #0: 22 / 0.537 -> en:hla-dp alpha-chains
    n1=en:hla-dp antigen | n2=en:hla-dp alpha-chains | rel=r_associated | relid=0 | w=22
  25. en:hla-dp antigen -- r_associated #0: 22 / 0.537 -> en:hla-dp serotyping
    n1=en:hla-dp antigen | n2=en:hla-dp serotyping | rel=r_associated | relid=0 | w=22
  26. en:hla-dp antigen -- r_associated #0: 22 / 0.537 -> en:hla-dq antigen
    n1=en:hla-dp antigen | n2=en:hla-dq antigen | rel=r_associated | relid=0 | w=22
  27. en:hla-dp antigen -- r_associated #0: 22 / 0.537 -> en:human leukocyte antigen hla-dw3 antigen
    n1=en:hla-dp antigen | n2=en:human leukocyte antigen hla-dw3 antigen | rel=r_associated | relid=0 | w=22
  28. en:hla-dp antigen -- r_associated #0: 22 / 0.537 -> en:immunology aspects
    n1=en:hla-dp antigen | n2=en:immunology aspects | rel=r_associated | relid=0 | w=22
  29. en:hla-dp antigen -- r_associated #0: 22 / 0.537 -> en:therapeutic use - qualifier
    n1=en:hla-dp antigen | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=22
  30. en:hla-dp antigen -- r_associated #0: 21 / 0.512 -> en:h-2 antigens
    n1=en:hla-dp antigen | n2=en:h-2 antigens | rel=r_associated | relid=0 | w=21
  31. en:hla-dp antigen -- r_associated #0: 21 / 0.512 -> en:hla-dpw3 antigen
    n1=en:hla-dp antigen | n2=en:hla-dpw3 antigen | rel=r_associated | relid=0 | w=21
  32. en:hla-dp antigen -- r_associated #0: 21 / 0.512 -> en:hla-dr antigen
    n1=en:hla-dp antigen | n2=en:hla-dr antigen | rel=r_associated | relid=0 | w=21
  33. en:hla-dp antigen -- r_associated #0: 21 / 0.512 -> en:hla-dw6 antigen
    n1=en:hla-dp antigen | n2=en:hla-dw6 antigen | rel=r_associated | relid=0 | w=21
  34. en:hla-dp antigen -- r_associated #0: 20 / 0.488 -> antigène hla-dp
    n1=en:hla-dp antigen | n2=antigène hla-dp | rel=r_associated | relid=0 | w=20
  35. en:hla-dp antigen -- r_associated #0: 20 / 0.488 -> effet d'un médicament
    n1=en:hla-dp antigen | n2=effet d'un médicament | rel=r_associated | relid=0 | w=20
  36. en:hla-dp antigen -- r_associated #0: 20 / 0.488 -> en:cd4-positive t-lymphocyte
    n1=en:hla-dp antigen | n2=en:cd4-positive t-lymphocyte | rel=r_associated | relid=0 | w=20
  37. en:hla-dp antigen -- r_associated #0: 20 / 0.488 -> en:hla class ii histocompatibility antigen, dp(w4) beta chain
    n1=en:hla-dp antigen | n2=en:hla class ii histocompatibility antigen, dp(w4) beta chain | rel=r_associated | relid=0 | w=20
  38. en:hla-dp antigen -- r_associated #0: 20 / 0.488 -> en:human
    n1=en:hla-dp antigen | n2=en:human | rel=r_associated | relid=0 | w=20
  39. en:hla-dp antigen -- r_associated #0: 20 / 0.488 -> en:mhc class ii protein
    n1=en:hla-dp antigen | n2=en:mhc class ii protein | rel=r_associated | relid=0 | w=20
  40. en:hla-dp antigen -- r_associated #0: 20 / 0.488 -> en:transmembrane protein
    n1=en:hla-dp antigen | n2=en:transmembrane protein | rel=r_associated | relid=0 | w=20
  41. en:hla-dp antigen -- r_associated #0: 20 / 0.488 -> human
    n1=en:hla-dp antigen | n2=human | rel=r_associated | relid=0 | w=20
  42. en:hla-dp antigen -- r_associated #0: 20 / 0.488 -> protéine membranaire
    n1=en:hla-dp antigen | n2=protéine membranaire | rel=r_associated | relid=0 | w=20
  43. en:hla-dp antigen -- r_associated #0: 20 / 0.488 -> Protéine membranaire
    n1=en:hla-dp antigen | n2=Protéine membranaire | rel=r_associated | relid=0 | w=20
≈ 46 relations entrantes

  1. Protéine membranaire --- r_associated #0: 55 --> en:hla-dp antigen
    n1=Protéine membranaire | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=55
  2. en:human --- r_associated #0: 53 --> en:hla-dp antigen
    n1=en:human | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=53
  3. effet d'un médicament --- r_associated #0: 49 --> en:hla-dp antigen
    n1=effet d'un médicament | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=49
  4. human --- r_associated #0: 49 --> en:hla-dp antigen
    n1=human | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=49
  5. protéine membranaire --- r_associated #0: 46 --> en:hla-dp antigen
    n1=protéine membranaire | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=46
  6. en:drug effect --- r_associated #0: 45 --> en:hla-dp antigen
    n1=en:drug effect | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=45
  7. en:transmembrane protein --- r_associated #0: 45 --> en:hla-dp antigen
    n1=en:transmembrane protein | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=45
  8. en:mechanism of action qualifier --- r_associated #0: 43 --> en:hla-dp antigen
    n1=en:mechanism of action qualifier | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=43
  9. en:hla-dq1 antigen --- r_associated #0: 41 --> en:hla-dp antigen
    n1=en:hla-dq1 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=41
  10. en:hla-dp alpha-chains --- r_associated #0: 39 --> en:hla-dp antigen
    n1=en:hla-dp alpha-chains | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=39
  11. en:h-2 antigens --- r_associated #0: 35 --> en:hla-dp antigen
    n1=en:h-2 antigens | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=35
  12. en:hla-dp antigens --- r_associated #0: 35 --> en:hla-dp antigen
    n1=en:hla-dp antigens | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=35
  13. en:hla-dpw2 antigen --- r_associated #0: 35 --> en:hla-dp antigen
    n1=en:hla-dpw2 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=35
  14. en:hla-dw13 antigen --- r_associated #0: 35 --> en:hla-dp antigen
    n1=en:hla-dw13 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=35
  15. en:hla-dw5 antigen --- r_associated #0: 35 --> en:hla-dp antigen
    n1=en:hla-dw5 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=35
  16. en:hla-dw1 antigen --- r_associated #0: 34 --> en:hla-dp antigen
    n1=en:hla-dw1 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=34
  17. en:hla-dw4 antigen --- r_associated #0: 34 --> en:hla-dp antigen
    n1=en:hla-dw4 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=34
  18. en:immunology aspects --- r_associated #0: 34 --> en:hla-dp antigen
    n1=en:immunology aspects | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=34
  19. en:therapeutic use - qualifier --- r_associated #0: 34 --> en:hla-dp antigen
    n1=en:therapeutic use - qualifier | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=34
  20. antigène hla-dp --- r_associated #0: 33 --> en:hla-dp antigen
    n1=antigène hla-dp | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=33
  21. antigène HLA-DP --- r_associated #0: 32 --> en:hla-dp antigen
    n1=antigène HLA-DP | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=32
  22. en:exposure as collected domain --- r_associated #0: 32 --> en:hla-dp antigen
    n1=en:exposure as collected domain | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=32
  23. en:hla-dp beta-chains --- r_associated #0: 32 --> en:hla-dp antigen
    n1=en:hla-dp beta-chains | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=32
  24. en:human leukocyte antigen hla-dw2 antigen --- r_associated #0: 32 --> en:hla-dp antigen
    n1=en:human leukocyte antigen hla-dw2 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=32
  25. en:bioformation --- r_associated #0: 31 --> en:hla-dp antigen
    n1=en:bioformation | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=31
  26. en:hla-dq4 antigen --- r_associated #0: 31 --> en:hla-dp antigen
    n1=en:hla-dq4 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=31
  27. en:hla-dr antigen --- r_associated #0: 31 --> en:hla-dp antigen
    n1=en:hla-dr antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=31
  28. en:cd4-positive t-lymphocyte --- r_associated #0: 30 --> en:hla-dp antigen
    n1=en:cd4-positive t-lymphocyte | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=30
  29. en:hla-dw14 antigen --- r_associated #0: 30 --> en:hla-dp antigen
    n1=en:hla-dw14 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=30
  30. en:hla-dw19 antigen --- r_associated #0: 30 --> en:hla-dp antigen
    n1=en:hla-dw19 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=30
  31. en:human leukocyte antigen hla-dw3 antigen --- r_associated #0: 30 --> en:hla-dp antigen
    n1=en:human leukocyte antigen hla-dw3 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=30
  32. HLA-DP --- r_associated #0: 29 --> en:hla-dp antigen
    n1=HLA-DP | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=29
  33. en:hla-dp serotyping --- r_associated #0: 29 --> en:hla-dp antigen
    n1=en:hla-dp serotyping | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=29
  34. en:hla-dpw3 antigen --- r_associated #0: 29 --> en:hla-dp antigen
    n1=en:hla-dpw3 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=29
  35. en:hla-dw15 --- r_associated #0: 29 --> en:hla-dp antigen
    n1=en:hla-dw15 | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=29
  36. en:hla-dr4 antigen --- r_associated #0: 28 --> en:hla-dp antigen
    n1=en:hla-dr4 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=28
  37. en:hla-dw6 antigen --- r_associated #0: 28 --> en:hla-dp antigen
    n1=en:hla-dw6 antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=28
  38. en:hla-dq antigen --- r_associated #0: 27 --> en:hla-dp antigen
    n1=en:hla-dq antigen | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=27
  39. en:hla-dw12 antigens --- r_associated #0: 27 --> en:hla-dp antigen
    n1=en:hla-dw12 antigens | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=27
  40. en:hla class ii histocompatibility antigen, dp(w4) beta chain --- r_associated #0: 26 --> en:hla-dp antigen
    n1=en:hla class ii histocompatibility antigen, dp(w4) beta chain | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=26
  41. en:mhc class ii protein --- r_associated #0: 26 --> en:hla-dp antigen
    n1=en:mhc class ii protein | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=26
  42. en:physiological aspects --- r_associated #0: 26 --> en:hla-dp antigen
    n1=en:physiological aspects | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=26
  43. HUman --- r_associated #0: 15 --> en:hla-dp antigen
    n1=HUman | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=15
  44. bienveillant --- r_associated #0: 10 --> en:hla-dp antigen
    n1=bienveillant | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=10
  45. hla-dp --- r_associated #0: 10 --> en:hla-dp antigen
    n1=hla-dp | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=10
  46. lymphocyte T CD4-positif --- r_associated #0: 5 --> en:hla-dp antigen
    n1=lymphocyte T CD4-positif | n2=en:hla-dp antigen | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr